Lefebvre Eric
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Lefebvre Eric. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PLRX | Chief Medical Officer | Award / Grant | 45,650 | — | — | Jan 23, 2025 |
| PLRX | Chief Medical Officer | Sale | 18,478 | $11.20 | $206,954 | Jan 17, 2025 |
| PLRX | Chief Medical Officer | Sale | 12,319 | $11.56 | $142,408 | Jul 10, 2024 |
| PLRX | Chief Medical Officer | Award / Grant | 24,063 | — | — | Jul 9, 2024 |
| PLRX | Chief Medical Officer | Award / Grant | 42,900 | — | — | Jan 23, 2024 |
| PLRX | Chief Medical Officer | Sale | 10,295 | $17.23 | $177,383 | Jan 17, 2024 |
| PLRX | Chief Medical Officer | Sale | 22,321 | $18.01 | $402,001 | Jul 17, 2023 |
| PLRX | Chief Medical Officer | Award / Grant | 43,750 | — | — | Jul 14, 2023 |
| PLRX | Chief Medical Officer | Sale | 11,245 | $26.52 | $298,217 | Mar 30, 2023 |
| PLRX | Chief Medical Officer | Award / Grant | 21,874 | — | — | Mar 29, 2023 |
| PLRX | Chief Medical Officer | Award / Grant | 57,000 | — | — | Jan 25, 2023 |
| PLRX | Chief Medical Officer | Sale | 67,500 | $34.48 | $2,327,400 | Jan 23, 2023 |
| PLRX | Chief Medical Officer | Sale | 10,887 | $19.10 | $207,942 | Dec 19, 2022 |
| PLRX | Chief Medical Officer | Sale | 5,000 | $25.05 | $125,250 | Oct 25, 2022 |
| PLRX | Chief Medical Officer | Sale | 3,000 | $20.00 | $60,000 | Jul 11, 2022 |
| PLRX | Chief Medical Officer | Sale | 3,728 | $29.43 | $109,715 | Jun 18, 2021 |
| PLRX | Chief Medical Officer | Sale | 11,365 | $39.38 | $447,554 | Mar 18, 2021 |
| PLRX | Chief Medical Officer | Sale | 5,712 | $26.98 | $154,110 | Dec 18, 2020 |